<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04707170</url>
  </required_header>
  <id_info>
    <org_study_id>JSY_2020_38</org_study_id>
    <nct_id>NCT04707170</nct_id>
  </id_info>
  <brief_title>MRI Exploration of Meningeal Inflammatory Disease</brief_title>
  <acronym>EIME</acronym>
  <official_title>MRI Exploration of Meningeal Inflammatory Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who have agreed to participate in the study will complete the MRI protocol as part&#xD;
      of routine care, to which two additional sequences of 6 minutes duration will be added.&#xD;
&#xD;
      The MRI of routine care includes at least the following sequences:&#xD;
&#xD;
        -  3D T1 TFE 1.0 isotropic (2 minutes)&#xD;
&#xD;
        -  T2 TSE (2 minutes)&#xD;
&#xD;
        -  3D FLAIR pre-injection (opt) (3 minutes)&#xD;
&#xD;
        -  3D FLAIR post-injection (3 minutes)&#xD;
&#xD;
      As part of the research, the following sequences will be acquired:&#xD;
&#xD;
        -  FABIR pre-injection (3 minutes)&#xD;
&#xD;
        -  FABIR post-injection (3 minutes)&#xD;
&#xD;
      Patients hospitalized for a foreseeable duration of at least 24 hours will be offered&#xD;
      participation in the longitudinal tab of the study, for which four non-injected MRI&#xD;
      examinations will be performed. The examinations will be carried out remotely from the&#xD;
      injected MRI (1h, 2h, 12h-15h, 24h-36h). These exams dedicated to research will include the&#xD;
      following sequences for a maximum of 8 minutes:&#xD;
&#xD;
        -  3D T1 TFE 1.0 isotropic (2 minutes)&#xD;
&#xD;
        -  3D FLAIR (3 minutes)&#xD;
&#xD;
        -  FABIR (3 minutes)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 16, 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>detection of meningeal contrast enhancement with the flair sequence</measure>
    <time_frame>1 DAY</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>detection of meningeal contrast enhancement with the FABIR sequence</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>MRI</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI with gadolinium injection</intervention_name>
    <description>Patients presenting for imaging for whom an MRI examination with gadolinium injection has been prescribed and who meet the inclusion and non-inclusion criteria will be offered to participate in the study.&#xD;
The patients included, hospitalized at the A. de Rothschild Foundation Hospital for at least 24 hours, may be included in the ancillary study to meet secondary objective number 5.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting for imaging for whom an MRI examination with gadolinium injection has&#xD;
        been prescribed and who meet the inclusion and non-inclusion criteria will be offered to&#xD;
        participate in the study.&#xD;
&#xD;
        The patients included, hospitalized at the A. de Rothschild Foundation Hospital for at&#xD;
        least 24 hours, may be included in the ancillary study to meet secondary objective number 5&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient over 18 years old&#xD;
&#xD;
          -  To benefit as part of his treatment of an MRI with injection of gadolinium&#xD;
&#xD;
          -  Express consent to participate in the study&#xD;
&#xD;
          -  Affiliate or beneficiary of a social security scheme&#xD;
&#xD;
        For the ancillary study to meet secondary endpoint number 5:&#xD;
&#xD;
          -  Patient over 18 years old&#xD;
&#xD;
          -  To benefit as part of his treatment of an MRI with injection of gadolinium&#xD;
&#xD;
          -  Hospitalized for an expected period of at least 48 hours after the time of inclusion&#xD;
&#xD;
          -  Express consent to participate in the study&#xD;
&#xD;
          -  Affiliate or beneficiary of a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient benefiting from a legal protection measure&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>julien savatovsky</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital fondation Adolphe de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>amélie YAVCHITZ</last_name>
    <phone>0148036454</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>julien savatovsky</last_name>
    <phone>0148036401</phone>
    <email>jsavatovsky@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hhopital fondation adolphe de rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amelie ya</last_name>
      <phone>0148036454</phone>
      <email>ayavchitz@for.paris</email>
    </contact>
    <investigator>
      <last_name>julien savatovsky</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

